Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2Phase 3 1

Status

Completed 7

Sponsor Class

INDUSTRY 5OTHER 1NIH 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7Sarcoma 6Lymphoid 6Genitourinary 6Tumor-Agnostic 4Plasma cell 4Other hematologic neoplasm 4CNS 3Thoracic 2Other solid neoplasm 2Myeloid 2Gynecologic 2Breast 2Head & Neck 1Dermatologic 1

Conditions

Pancreatic Neoplasms 2Colonic Neoplasms 2Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × perifosine × Gastrointestinal × Clear all
NCT01048580 2018-06-28

Study of Perifosine + Capecitabine for Colon Cancer Patients

AEterna Zentaris

Phase 1 Completed
10 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00398879 2018-03-14

Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients

AEterna Zentaris

Phase 2 Completed
381 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00455559 2018-02-22

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

AEterna Zentaris

Phase 2 Completed
40 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00053924 2015-07-23

Perifosine in Treating Patients With Advanced Pancreatic Cancer

University Health Network, Toronto

Phase 2 Completed
Gastrointestinal

Pancreatic Neoplasms

NCT00398814 2014-02-19

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

AEterna Zentaris

Phase 1 Completed
30 enrolled
GastrointestinalGenitourinary

Kidney Neoplasms, Liver Neoplasms, Neoplasms

NCT01097018 2013-07-02

X-PECT

AEterna Zentaris

Phase 3 Completed
468 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00059982 2013-06-24

Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡